# Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents

Study · id `cardio:ct-nct04250116` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04250116](<https://clinicaltrials.gov/study/NCT04250116>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04250116

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 960 participants.

## Technical summary

Registry record NCT04250116. Randomized; no masking; primary purpose treatment. Start 2020-04-28 (actual); primary completion 2026-05-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 960 participants (enrolled count; ClinicalTrials.gov record NCT04250116, source copy `cardio:ctgov-nct04250116-2026-09-04`, retrieved 2026-10-26)
- Started: 2020-04-28 (actual) (ClinicalTrials.gov record NCT04250116, source copy `cardio:ctgov-nct04250116-2026-09-04`, retrieved 2026-10-26)
- Primary completion: 2026-05-08 (actual) (ClinicalTrials.gov record NCT04250116, source copy `cardio:ctgov-nct04250116-2026-09-04`, retrieved 2026-10-26)
- Completion: 2026-05-08 (actual) (ClinicalTrials.gov record NCT04250116, source copy `cardio:ctgov-nct04250116-2026-09-04`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT04250116, source copy `cardio:ctgov-nct04250116-2026-09-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04250116-2026-09-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents
- Condition: Atrial Fibrillation
- Intervention (Drug): NOAC monotherapy
- Intervention (Drug): Dual antithrombotic therapy with NOAC and clopidogrel
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Antithrombotic Therapy in Patients With Atrial Fibrillation With Prior Complex PCI: A Secondary Analysis of the Randomized ADAPT AF-DES Trial (`cardio:pubmed-42464814`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 31e55e4a4b299171963dbe4683ee1921cbd26f03f0510e92b6132f65c83a3ba0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
